The major difference between the T cells from healthy persons and that from patients with cancer, especially those with advanced cancer, is that the latter express more checkpoint molecules, such as PD-1 through the signaling of cancer cells, while the cancer cells express the inhibitory ligands (such as PD-L1) of checkpoints. This evidence concerns the gene CD274 and cancer.